A 55-year-old patient with Type 2 Diabetes Mellitus currently on metformin 1000 mg twice daily has an HbA1c of 8.5%. She has no history of cardiovascular disease or heart failure. What is the most appropriate next step in her management?

✓ Correct Answer: Option D

For T2DM patients with HbA1c >8.0% on metformin monotherapy without CVD, current guidelines recommend adding a GLP-1 receptor agonist or SGLT2 inhibitor. GLP-1 RAs provide good A1c reduction and can also aid in weight loss.